[
    {
        "Visit Number  ": "",
        "Screening  ": "1  ",
        "Placebo-Controlled Phasea  ": "Baseline 2  ",
        "3  ": "3  ",
        "4  ": "4  ",
        "5  ": "5  ",
        "Apremilast Extension Phaseb  ": "6  ",
        "7  ": "7  ",
        "8  ": "8  ",
        "9/ETc  ": "9/ETc  ",
        "Post-Treatment Observational Follow-upd  ": "56 (or 4 weeks after study discontinuation)  "
    },
    {
        "Visit Number  ": "Week  ",
        "Screening  ": "-35 to 0 days  ",
        "Placebo-Controlled Phasea  ": "0 (Day 1)  ",
        "3  ": "(\u00b1 3 days)  2  ",
        "4  ": "4  (\u00b1 3 days)  ",
        "5  ": "16 (\u00b1 3 days)  ",
        "Apremilast Extension Phaseb  ": "20 (\u00b1 4 days)  ",
        "7  ": "32 (\u00b1 4 days)  ",
        "8  ": "44 (\u00b1 4 days)  ",
        "9/ETc  ": "52 (\u00b1 4 days)  ",
        "Post-Treatment Observational Follow-upd  ": null
    },
    {
        "Visit Number  ": "Dispense IP  ",
        "Screening  ": "- ",
        "Placebo-Controlled Phasea  ": "X  ",
        "3  ": "- ",
        "4  ": "X  ",
        "5  ": "X  ",
        "Apremilast Extension Phaseb  ": "X  ",
        "7  ": "X  ",
        "8  ": "X  ",
        "9/ETc  ": "- ",
        "Post-Treatment Observational Follow-upd  ": "- "
    },
    {
        "Visit Number  ": "Return and Count IP Tablets  ",
        "Screening  ": "- ",
        "Placebo-Controlled Phasea  ": "- ",
        "3  ": "- ",
        "4  ": "X  ",
        "5  ": "X  ",
        "Apremilast Extension Phaseb  ": "X  ",
        "7  ": "X  ",
        "8  ": "X  ",
        "9/ETc  ": "X  ",
        "Post-Treatment Observational Follow-upd  ": "- "
    }
]